Genzyme Veteran Gives $10m to Open Personalized Medicine Center at Mass General

September 15, 2011

September 15, 2011 | Retired biotech executive Henri Termeer, who built Genzyme Corp, is donating $10 million to Massachusetts General Hospital to establish it as a leader in personalized medicne. The new Henri and Belinda Termeer Center for Targeted Therapies will be aimed at bringing the emerging field into the forefront of treatment and research. Its initial focus will be on drugs tailored to the genetic makeup of tumors, especially breast cancers, lung cancers, and leukemias. Boston Globe